MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models (Q27683975)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models |
scientific article |
Statements
MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models (English)
0 references
15 April 2013
0 references
73
0 references
8
0 references
2587-97
0 references